Distribution of Streptococcus pneumoniae serotypes that cause parapneumonic empyema in Turkey

Clinical and Vaccine Immunology

Volumn 20, Issue 7, 2013, Pages 972-976

  Ceyhan, Mehmet ^a   Ozsurekci, Yasemin ^a   Gur̈ler, Nezahat ^b   Ozkan, Sengul ^c   Sensoy, Gulnar ^d   Belet, Nursen ^d   Hacimustafaoglu, Mustafa ^e   Celebi, Solmaz ^e   Keser, Melike ^f   Dinleyici, Ener Cagri ^g   Alhan, Emre ^h   Baki, Ali ⁱ   Oner, Ahmet Faik ^j   Uzun, Hakan ^k   Kurugol, Zafer ^l   Aycan, Ahmet Emre ^a   Gurbuz, Venhar ^a   Oncel, Eda Karadag ^a   Celik, Melda ^a   Parlakay, Aslinur Ozkaya ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c DR SAMI ULUS CHILDREN S HOSPITAL   (Turkey)

^d ONDOKUZ MAYIS UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^e ULUDAG UNIVERSITY   (Turkey)

^f SELCUK UNIVERSITY   (Turkey)

^g OSMANGAZI UNIVERSITY MEDICAL FACULTY   (Turkey)

^h CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

ⁱ KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^j YUZUNCU YIL UNIVERSITY   (Turkey)

^k DUZCE UNIVERSITY   (Turkey)

^l EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PCV 7; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIGEN DETECTION; ARTICLE; BACTERIUM ISOLATE; CAUSAL ATTRIBUTION; CHILD; CHILD HEALTH; CLINICAL ARTICLE; EMPYEMA; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNE STATUS; INFANT; MALE; MIXED INFECTION; NONHUMAN; PARAPNEUMONIC EMPYEMA; PRESCHOOL CHILD; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; TURKEY (REPUBLIC); VACCINATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; EMPYEMA; FEMALE; HOSPITALS; HUMANS; INFANT; MALE; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; PROSPECTIVE STUDIES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; TURKEY;

EID: 84880451882     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00765-12     Document Type: Article

References (42)

1. Byington CL, Spencer LY, Johnson TA, Pavia AT, Allen D, Mason EO, Kaplan S, Carroll KC, Daly JA, Christenson JC, Samore MH. 2002. An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin. Infect. Dis. 34:434-440. (Pubitemid 34112262)
2. Grisaru-Soen G, Eisenstadt M, Paret G, Schwartz D, Keller N, Nagar H, Reif S. 2013. Pediatric parapneumonic empyema: risk factors, clinical characteristics, microbiology, and management. Pediatr. Emerg. Care 29: 425-429.
3. Chonmaitree T, Powell KR. 1983. Parapneumonic pleural effusion and empyema in children: review of a 19-year experience, 1962-1980. Clin. Pediatr. (Phila.) 22:414-419. (Pubitemid 13099271)
4. Varkey B, Rose HD, Kutty CP, Politis J. 1981. Empyema thoracis during a ten year period: analysis of 72 cases and comparison to a previous study (1952-1967). Arch. Intern. Med. 141:1771-1776. (Pubitemid 12244672)
5. Freij BJ, Kusmiesz H, Nelson JD, McCracken GH, Jr. 1984. Parapneumonic effusions and empyema in hospitalized children: a retrospective review of 227 cases. Pediatr. Infect. Dis. 3:578-591. (Pubitemid 15220607)
6. Friedland IR, McCracken GH, Jr. 1994. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N. Engl. J. Med. 331:377-382. (Pubitemid 24984708)
7. Mastro TD, Ghafoor A, Nomani NK, Ishaq Z, Anwar F, Granoff DM, Spika JS, Thornsberry C, Facklam RR. 1991. Antimicrobial resistance of pneumococci in children with acute lower respiratory tract infection in Pakistan. Lancet 337:156-159.
8. Friedland IR, Klugman KP. 1992. Antibiotic-resistant pneumococcal disease in South African children. Am. J. Dis. Child. 146:920-923.
9. Nuorti JP, Whitney CG, Centers for Disease Control and Prevention (CDC). 2010. Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 59:1-18.
10. Byington CL, Samore MH, Stoddard GJ, Barlow S, Daly J, Korgenski K, Firth S, Glover D, Jensen J, Mason EO, Shutt CK, Pavia AT. 2005. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clin. Infect. Dis. 41:21-29. (Pubitemid 40863739)
11. Tan TQ, Mason EO, Jr, Wald ER, Barson WJ, Schutze GE, Bradley JS, Givner LB, Yogev R, Kim KS, Kaplan SL. 2002. Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics 110:1-6. (Pubitemid 34742634)
12. Schultz KD, Fan LL, Pinsky J, Ochoa L, Smith EO, Kaplan SL, Brandt ML. 2004. The changing face of pleural empyemas in children: epidemiology and management. Pediatrics 113:1735-1740. (Pubitemid 38697984)
13. Rees JH, Spencer DA, Parikh D, Weller P. 1997. Increase in incidence of childhood empyema in West Midlands, U. K. Lancet 349:402. doi: 10.1016/S0140-6736(97)80022-0. (Pubitemid 27077678)
14. Finley C, Clifton J, Fitzgerald JM, Yee J. 2008. Empyema: an increasing concern in Canada. Can. Respir. J. 15:85-89. (Pubitemid 351676396)
15. Gupta R, Crowley S. 2006. Increasing paediatric empyema admissions. Thorax 61:179-180.
16. Playfor SD, Smyth AR, Stewart RJ. 1997. Increase in incidence of childhood empyema. Thorax 52:932.
17. Fletcher M, Leeming J, Cartwright Finn KA. 2006. Childhood empyema: limited potential impact of 7-valent pneumococcal conjugate vaccine. Pediatr. Infect. Dis. J. 25:559-560. (Pubitemid 43863370)
18. Spencer DA, Iqbal SM, Hasan A, Hamilton L. 2006. Empyema thoracis is still increasing in UK children. BMJ 332:1333. doi:10.1136/bmj.332.7553.1333. (Pubitemid 44365394)
19. Byington CL, Korgenski K, Daly J, Ampofo K, Pavia A, Mason EO. 2006. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr. Infect. Dis. J. 25:250-254. (Pubitemid 43379067)
20. Hendrickson DJ, Blumberg DA, Joad JP, Jhawar S, McDonald RJ. 2008. Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine. Pediatr. Infect. Dis. J. 27:1030-1032.
21. Hardie W, Bokulic R, Garcia VF, Reising SF, Christie CDC. 1996. Pneumococcal pleural empyemas in children. Clin. Infect. Dis. 22:1057-1063. (Pubitemid 26260612)
22. Ceyhan M, Yildirim I, Balmer P, Borrow R, Dikici B, Turgut M, Kurt N, Aydogan A, Ecevit C, Anlar Y, Gulumser O, Tanir G, Salman N, Gurler N, Hatipoglu N, Hacimustafaoglu M, Celebi S, Coskun Y, Alhan E, Celik U, Camcioglu Y, Secmeer G, Gur D, Gray S. 2008. A prospective study of etiology of childhood acute bacterial meningitis, Turkey. Emerg. Infect. Dis. 14:1089-1096. (Pubitemid 351920439)
23. Ceyhan M, Yildirim I, Sheppard CL, George RC. 2010. Pneumococcal serotypes causing pediatric meningitis in Turkey: application of a new technology in the investigation of cases negative by conventional culture. Eur. J. Clin. Microbiol. Infect. Dis. 29:289-293.
24. Byington CL, Hulten KG, Ampofo K, Sheng X, Pavia AT, Blaschke AJ, Pettigrew M, Korgenski K, Daly J, Mason EO. 2010. Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah. J. Clin. Microbiol. 48:520-525.
25. Buckingham SC, King MD, Miller ML. 2003. Incidence and etiologies of complicated parapneumonic effusions in children, 1996 to 2001. Pediatr. Infect. Dis. J. 22:499-504. (Pubitemid 36782188)
26. Eastham KM, Freeman R, Kearns AM, Eltringham G, Clark J, Leeming J, Spencer DA. 2004. Clinical features, aetiology and outcome of empyema in children in the north east of England. Thorax 59:522-525. (Pubitemid 38797527)
27. Obando I, Munoz-Almagro C, Arroyo LA, Tarrago D, Sanchez-Tatay D, Moreno-Perez D, Dhillon SS, Esteva C, Hernandez-Bou S, Garcia- Garcia JJ, Hausdorff WP, Brueggemann AB. 2008. Pediatric parapneumonic empyema, Spain. Emerg. Infect. Dis. 14:1390-1397.
28. Eltringham G, Kearns A, Freeman R, Clark J, Spencer D, Eastham K, Harwood J, Leeming J. 2003. Culture-negative childhood empyema is usually due to penicillin-sensitive Streptococcus pneumoniae capsular serotype 1. J. Clin. Microbiol. 41:521-522. (Pubitemid 36098641)
29. Moore MR, Gertz RE, Jr, Woodbury RL, Barkocy-Gallagher GA, Schaffner W, Lexau C, Gershman K, Reingold A, Farley M, Harrison LH, Hadler JL, Bennett NM, Thomas AR, McGee L, Pilishvili T, Brueggemann AB, Whitney CG, Jorgensen JH, Beall B. 2008. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J. Infect. Dis. 197:1016-1027. (Pubitemid 351590031)
30. Pai R, Moore MR, Pilishuili T, Gertz RE, Whitney CG, Beall B; Active Bacterial Core Surveillance Team. 2005. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J. Infect. Dis. 192:1988-1995. (Pubitemid 41681898)
31. Pelton SI, Huot H, Finkelstein JA, Bishop CJ, Hsu KK, Kellenberg J, Huang SS, Goldstem R, Hanage WP. 2007. Emergence of 19A as a virulent and multidrug resistant pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr. Infect. Dis. J. 26:468-472. (Pubitemid 46847304)
32. Singleton RJ, Hennessy TW, Bulkow LR, Hammitt LL, Zulz T, Hurlburt DA, Butler JC, Rudolph K, Parkinson A. 2007. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 297:1784-1792. (Pubitemid 46658647)
33. Rückinger S, von Kries R, Siedler A, van der Linden M. 2009. Association of serotype of Streptococcus pneumoniae with risk of severe and fatal outcome. Pediatr. Infect. Dis. J. 28:118-122.
34. Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, Elvin L, Ensor KM, Hackell J, Siber G, Malinoski F, Madore D, Chang I, Kohberger R, Watson W, Austrian R, Edwards K. 2000. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr. Infect. Dis. J. 19:187-195. (Pubitemid 30167436)
35. Black SB, Shinefield HR, Ling S, Hansen J, Fireman B, Spring D, Noyes J, Lewis E, Ray P, Lee J, Hackell J. 2002. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr. Infect. Dis. J. 21:810-815.
36. O'Brien KL, Moulton LH, Reid R, Weatherholtz R, Oski J, Brown L, Kumar G, Parkinson A, Hu D, Hackell J, Chang I, Kohberger R, Siber G, Santosham M. 2003. Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial. Lancet 362:355-361. (Pubitemid 36945058)
37. Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, Pierce N, Vaccine Trialists Group. 2003. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N. Engl. J. Med. 349:1341-1348. (Pubitemid 37186212)
38. Cutts FT, Zaman SM, Enwere G, Jaffar S, Levine OS, Okoko JB, Oluwalana C, Vaughan A, Obaro SK, Leach A, McAdam KP, Biney E, Saaka M, Onwuchekwa U, Yallop F, Pierce NF, Greenwood BM, Adegbola RA; Gambian Pneumococcal Vaccine Trial Group. 2005. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-bind, placebo-controlled trial. Lancet 365:1139-1146. (Pubitemid 40417563)
39. Kaplan SL, Mason EO, Jr, Wald ER, Schutze GE, Bradley JS, Tan TQ, Hoffman JA, Givner LB, Yogev R, Barson WJ. 2004. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics 113:443-449. (Pubitemid 38280781)
40. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennet NM, Lynfield R, Reingold A, Cieslak PR, Pilishvili T, Jackson D, Facklam RR, Jorgensen JH, Schuchat A; Active Bacterial Core Surveillance of the Emerging Infections Program Network. 2003. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N. Engl. J. Med. 348:1737-1746. (Pubitemid 36514704)
41. Vesikari T, Wysocki J, Chevallier B, Karvonen A, Czajka H, Arsene JP, Lommel P, Dieussaert I, Schverman L. 2009. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine. Pediatr. Infect. Dis. J. 28:S66 -S76.
42. Vanderkooi OG, Scheifele DW, Girgenti D, Halperin SA, Patterson SD, Gruber WC, Emini EA, Scott DA, Kellner JD, Canadian PCV13 Study Group. 2012. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers given with routine pediatric vaccinations in Canada. Pediatr. Infect. Dis. J. 31:72-77.